Kev siv kom raug peptides poob phaus yuav tsum nyob rau hauv kev taw qhia ntawm kws kho mob, ua ke nrog kev noj haus thiab kev tawm dag zog. Nws lub luag haujlwm tseem ceeb yog txhawm rau txo qis qab los noj mov thiab tswj cov metabolism. Nws yog tsim nyog rau cov neeg rog rog uas muaj BMI ntau dua lossis sib npaug li 27 thiab sib npaug, lossis BMI Ntau dua lossis sib npaug li 30. Nws yog siv los ntawm kev txhaj tshuaj subcutaneous, nrog rau cov tshuaj maj mam nce ntxiv los txo cov kev mob tshwm sim.
Peptides poob phaus tsis yog ib qho luv luv rau kev poob phaus sai, tab sis yog txoj hauv kev kho mob uas xav tau kev tswj hwm kev tshawb fawb. Cov hauv qab no yog cov lus piav qhia ntxaws txog lawv cov teebmeem, cov neeg tsim nyog, thiab cov kev siv:
Cov teebmeem tseem ceeb ntawm Poob Poob Peptides
Peptides poob phaus (xws li liraglutide, smegglutide, thiab telpoglutide) yog GLP-1 receptor agonists, feem ntau ua haujlwm los ntawm cov txheej txheem hauv qab no:
Suppressing Appetite: Ua rau lub hlwb lub chaw satiety kom txo tau kev tshaib kev nqhis.
Kev ncua lub plab zom mov: Ua kom qeeb ntawm kev zom zaub mov thiab ncua sij hawm satiety.
Kev tswj cov ntshav qab zib thiab cov metabolism: txhim kho insulin rhiab heev thiab txo qhov kev pheej hmoo ntawm cov rog.
Cov ntaub ntawv kho qhov hnyav: Smegglutide ua rau qhov hnyav poob ntawm 17% (kwv yees li 16.8 kg). Telboride tau ua tiav qhov poob siab tshaj plaws ntawm 20.9% hauv kev sim. Liraglutide, ntawm ib hnub koob tshuaj 1.8 mg, ua rau poob phaus ntau dua 2.6 kg (hauv 12 lub lis piam).